A prospective observational study examined the spectrum of infantile dermatoses among infants aged 29 days to 12 months presenting at a rural tertiary care center in North India, with results published in Cureus.

The study design is straightforward but uncommon in this clinical space: rather than retrospectively reviewing charts, the investigators enrolled infants prospectively as they presented to the center, covering the post-neonatal infant period defined as 29 days to 12 months of age. That age window matters for dermatologists. It excludes neonatal dermatoses — conditions tied to birth and the first four weeks of life — and captures the period when infantile skin disorders first emerge and differentiate.

The setting carries as much weight as the design. Rural tertiary care centers in North India serve a patient population with distinctive dermatologic profiles: high environmental exposure, delayed referral patterns, and limited access to specialty dermatology at the primary care level. Studies from comparable centers have repeatedly shown that the distribution of pediatric skin disease in such settings diverges from what outpatient dermatology literature based on urban, Western cohorts describes.

Why does prospective enrollment matter here?

Prospective observational designs reduce the misclassification and missing-data problems that weaken retrospective dermatosis surveys. For a condition spectrum study — one aiming to describe which dermatoses occur, in what proportion, and with what clinical features — prospective capture at the point of presentation gives incidence-like frequency data that chart reviews cannot reliably produce.

The infant cohort itself is the second methodological anchor. Infants between 29 days and 12 months are a distinct physiologic group: the skin barrier is still maturing, immune responses are developing, and several dermatoses of infancy — including infantile seborrheic dermatitis, atopic dermatitis, and transient neonatal eruptions with delayed presentation — have age-timed onsets. Narrowing the cohort to this window sharpens the clinical relevance of the frequency data the study reports.

What can clinicians take from a single-center rural study?

Single-center studies do not establish prevalence for a region, and the authors frame their work within that constraint. What a study of this type does provide:

• A documented frequency profile of dermatoses in infants presenting to one rural tertiary referral center
• Clinical pattern data from direct prospective examination rather than record extraction
• A reference point for dermatologists and pediatricians triaging infant skin complaints in comparable rural settings

For dermatology practitioners in referral practice, the value lies in the comparison. Where tertiary data from rural North India diverge from published urban cohorts, the divergence itself signals access, referral-delay, or environmental factors that shape who actually reaches a dermatologist's table.

The larger context

Pediatric dermatosis surveys from India have consistently reported high burdens of infection-associated and eczematous conditions among infants, in contrast to the predominance of atopic disease in high-income-country cohorts. Each new prospective dataset from a rural tertiary center adds resolution to that picture and informs how dermatology services and training prioritize infant skin disease where referral capacity is thin.

The Cureus publication makes the full methodology, enrollment criteria, and dermatosis distribution available for clinicians who want to benchmark their own patient mix against a prospective rural cohort. As dermatology research pushes toward more representative, non-urban data, studies like this one will help define what infant skin disease looks like at the point where most of the world's infants actually receive care.